The Colorado BioScience Association (CBSA) worked with Senator Michael Bennet's office in assembling a group of more than 35 bioscience industry CEOs from its membership to dialogue with the Senator and Margaret Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (FDA). Dr. Jeffrey Shuren, Director, Center for Devices and Radiological Health, and Dr. Vicki Seyfert-Margolis, Senior Science Advisor to the FDA’s Chief Scientist, accompanied Commissioner Hamburg here.
The announcement is made by Holli Riebel (formerly Baumunk), CBSA President & CEO, who says "Senator Bennet invited Commissioner Hamburg and her colleagues to Colorado for the CEO Roundtable. The session is a positive next step to work CBSA has already contributed to Senator Bennet's Coloradoans For An Innovation Economy (CFAIE), and speaks strongly to the work the Senator is doing on our industry's behalf. We appreciate the opportunity to host Commissioner Hamburg in our state for the first time and share our industry's specific and unique needs for bringing innovative drugs and devices to market under current, often constraining, market conditions."
According to Lilly Marks, VP for Health Affairs and Executive Vice Chancellor, Anschutz Medical Campus, the Roundtable session took place on the Anschutz Medical Campus in Aurora where the FDA delegation also toured research and clinical trial facilities before departing the city.
Link to the Business Wire release
No comments:
Post a Comment